ISSN 2411-0272 (Online)
ISSN 2411-0485 (Print)
 
 
Home | Current Issue | Editorial Board | About Us
 

Home

Editorial Board
Archive
Current Issue
Author Guidelines
Submit a Manuscript
Track your manuscript
Reviewer Information
Reviewer's Form
Indexing
About Us
Contact Us

Effect of PTPRδ rs17584499 C/T Polymorphism on Therapeutic Efficacy of Metformin in Bangladeshi Patients with Type 2 Diabetes.


Rokeya Begum1*, Subhagata Choudhury2, Zafar Ahmed Latif2 and Gazi Nurun Nahar Sultana1

1.Center for Advanced Research in Sciences, University of Dhaka Email: rokeya@du.ac.bd. Ibrahim Memorial Diabetic Center Email: subhagata.bd@gmail.com 2. Ibrahim Memorial Diabetic Center Email:zafaralatif2011@yahoo.com 1. Center for Advanced Research in Sciences, University of DhakaEmail:nngazi@gmail.com Email:nngazi@gmail.com

ABSTRACT: Type 2 diabetes mellitus (T2DM) is a polygenic and complex disorder that is difficult to treat effectively in the long term without oral anti-diabetic agents. Genetic variants of these susceptible genes provided the new targets for prevention, diagnosis and treatment of T2DM. Metformin is the first-line agent for T2DM patients that reduces gluconeogenesis by increasing hepatic sensitivity to insulin. To investigate the effect of the rs17584499 C/T polymorphism on metformin therapeutic efficacy in BangladeshiT2DM patients, a fragment of 540 bp of protein tyrosine receptor type delta (PTPRδ) was analysed in 50 T2DM patients having only metformin and 25 healthy controls. In this study it was revealed that T2DM patients having only metformin to treat their disease for 3.622.97 years managed their glucose level and lipid profile to within the reference value. Two additional SNPs (rs1978741G/A and rs7865131C/G) within target SNP rs17584499 C/T were also identified. It was found that, the probability of the association of target rs17584499 C/T and newly identified rs1978741G/A with development of T2DM and their effect on metformin therapeutic effect on metformin in Bangladeshi T2DM patients is very low. But carriers of another newly identified rs7865131C/G: the G allele might be having higher susceptibility to T2DM as well as might have adverse effect on therapeutic effect on metformin in patients with T2DM.

KEYWORDS: Type 2 diabetes mellitus (T2DM), Metformin, Bangladesh, Polymorphism, Therapeutic effect.

CITATION: Begum, R., Choudhury, S., Latif, Z. A., Sultana G. N. N. 2016. Effect of PTPRδ rs17584499 C/T Polymorphism on Therapeutic Efficacy of Metformin in Bangladeshi Patients with Type 2 Diabetes. Biores Comm. 2(1), 182-188.

CORRESPONDENCE: Rokeya Begum, E-mail: rokeya@du.ac.bd

 

 
 
Copyright (c) Bio Research.Com
All rights reserved.develop by YogSutrA